Japan’s Eisai aims for 2030 U.S. release of new Alzheimer’s drug – Nikkei Asia
TOKYO — Japanese pharmaceutical company Eisai is developing an Alzheimer’s disease treatment that targets a protein linked to symptoms, …Read More
The Heartbeat of World events
TOKYO — Japanese pharmaceutical company Eisai is developing an Alzheimer’s disease treatment that targets a protein linked to symptoms, …Read More